News publication
Everything we hold that ferronova.com.au published.
Every article we hold from ferronova.com.au.
Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.
Also movefm.com.au
Under Business News Australia ·leads this story in the feed
Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.
Cancer-detection nanotech developer Ferronova announced a $3.5 million Series A round, with Uniseed leading, to fund planned human trials across several cancer types; research partners span four universities.
Deals recorded from ferronova.com.au's coverage. A round is listed once, however many of their articles mention it.
| Company | Stage | Announced | Amount | Investors |
|---|---|---|---|---|
| FerronovaPrecision cancer treatment technology | Series A | 17 Dec 2025 | $6m |
Companies named in ferronova.com.au's articles, most-covered first.
Investors named in ferronova.com.au's articles, most-covered first.
| Investor | What it does | Articles |
|---|---|---|
| Artesian VC | Alternative asset management for debt and venture capital | 3 |
| Australian Government | 1 | |
| Renew Pharmaceuticals | 2 | |
| South Australian Venture Capital Fund | 2 | |
| Uniseed | Venture fund backing early-stage deep tech and life science companies | 2 |
| Uniseed/UniSuper | 1 |